ADIAL PHARMACEUTICALS RECEIVES NOTICE OF ALLOWANCE FROM US PATENT AND TRADEMARK OFFICE FOR PATENT FOR THE TREATMENT OF ALCOHOL USE DISORDER IN PATIENTS IDENTIFIED USING A MOLECULAR GENETIC BIOMARKER
16331
post-template-default,single,single-post,postid-16331,single-format-link,bridge-core-1.0.6,ajax_fade,page_not_loaded,,qode-theme-ver-18.2,qode-theme-bridge,disabled_footer_top,qode_header_in_grid,wpb-js-composer js-comp-ver-6.0.5,vc_responsive

ADIAL PHARMACEUTICALS RECEIVES NOTICE OF ALLOWANCE FROM US PATENT AND TRADEMARK OFFICE FOR PATENT FOR THE TREATMENT OF ALCOHOL USE DISORDER IN PATIENTS IDENTIFIED USING A MOLECULAR GENETIC BIOMARKER